Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating an immunomodulatory therapy for moderate to severe COVID-19 has completed enrollment and results are likely reported…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Infection

Drugs mentioned

• Immunomodulatory Therapy

Snippet

Sponsor: Bosnalijek D.D | Conditions: COVID-19 Infection | Phase 2, Phase 3 | Status: COMPLETED